MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED

This adverse event was reported 14 times

These drugs are most commonly taken by patients reporting MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED:

# Drug Count
0 GEFITINIB 9
1 BEVACIZUMAB 1
2 DENOSUMAB 1
3 ETHIODIZED OIL 1
4 FLUOROURACIL 1
5 FLUOROURACIL CREAM, 0.5% 1
6 INCLISIRAN 1
7 MEROPENEM 1
8 OXALIPLATIN 1
9 PEMETREXED DISODIUM 1
See all common drugs associated with MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED

MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 GEFITINIB 9 0.0010
1 ETHIODIZED OIL 1 0.0008
2 INCLISIRAN 1 0.0001
3 MEROPENEM 1 0.0000
4 PEMETREXED DISODIUM 1 0.0000
5 OXALIPLATIN 1 0.0000
6 FLUOROURACIL CREAM, 0.5% 1 0.0000
7 FLUOROURACIL 1 0.0000
8 BEVACIZUMAB 1 0.0000
9 DENOSUMAB 1 0.0000
See all drugs enriched for association with MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED

MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Radiographic Contrast Agent [EPC] 1 0.0000
1 Penem Antibacterial [EPC] 1 0.0000
2 Kinase Inhibitor [EPC] 9 0.0000
3 Interleukin-23 Antagonist [EPC] 1 0.0000
4 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
5 RANK Ligand Inhibitor [EPC] 1 0.0000
6 Platinum-based Drug [EPC] 1 0.0000
7 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with MITOCHONDRIAL ASPARTATE AMINOTRANSFERASE INCREASED